Search

Search Results

• The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

  Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

  01-07-2025

  https://doi.org/10.4081/dr.2025.10112

  684

  PDF: 491

  HTML: 8

• Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study

  Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Santo Raffaele Mercuri, Gianluca Nazzaro, Giulia Spallone, Giovanni Paolino, Marco Ardigò

  18-02-2025

  https://doi.org/10.4081/dr.2025.10196

  544

  PDF: 460

  HTML: 10

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2651

  PDF: 968

  HTML: 28
• 

  25 | A phase II, open-label study to improve compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas – the SONIBEC trial Monica Variolo^1|2, Carlo Resteghini^1|2, Sara Farinatti^1|2, Andrea Alberti³, Valeria Tovazzi³, Paola Queirolo⁴, Maristella Saponara⁴, Giuseppe Argenziano⁵, Riccardo Marconcini⁶, Ketty Peris⁷, Paola Savoia⁸, Maria Chiara Tronconi¹, Iris Zalaudek⁹, Paolo Ascierto¹⁰, Francesco Spagnolo¹¹, Luigi Lorini¹, Cristina Gurizzan¹, Paolo Bossi^1|2 | ¹Medical Oncology and Haematology Unit, IRCCS Humanitas Research Hospital, Rozzano ^MI; ²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan; ³Medical Oncology Unit, ASST Spedali Civili, Brescia; ⁴Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan; ⁵Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples; ⁶Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa; ⁷Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome; ⁸Department of Health Sciences, University of Eastern Piedmont, Novara; ⁹Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Trieste; ¹⁰Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples; ¹¹Department of Medical Oncology, IRCCS AOU San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10767

  288
• 

  Metastatic extramammary paget disease, a remarkable clinical case and a brief review of a rare disease

  Leonor Fernandes, Joana Graça, Leonor Vasconcelos de Matos, Rita Sampaio, Mafalda Miranda Baleiras, Filipa Ferreira, Marta Mesquita Pinto, Helena Miranda, Ana Martins

  22-10-2020

  https://doi.org/10.4081/dr.2020.8841

  1039

  PDF: 574

  HTML: 30
• 

  33 | A single center, real world experience with hedgehog pathway inhibitors in advanced basal cell carcinoma Giulia Gibilisco¹, Ramiz Anwar Rana¹, Vincenzo D’Alonzo¹, Maura Colucci^1|2, Monica Valente², Elisa Cinotti³, Giovanni Rubino⁴, Valentina Croce¹, Eleonora Carbonari¹, Matteo Ravara¹, Tommaso Sani¹, Maria Lo Fiego¹, Alessia Covre¹, Serena Cutarella¹, Roberto Cuomo⁵, Luca Grimaldi⁵, Pietro Rubegni³, Michele Maio^1|2, Anna Maria Di Giacomo^1|2 | ¹University of Siena; ²Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena; ³Dermatology Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; ⁴Radiotherapy Unit, Department of Oncology, University Hospital of Siena; ⁵Plastic Surgery Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; ⁶NIBIT Foundation Onlus, Genoa, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10775

  297
• 

  13 | Spatial contexture of tertiary lymphoid structures as a predictor of recurrence in early-stage melanoma Chiara Bungaro¹, Sabino Strippoli¹, Daniele Carenza¹, Ivana De Risi¹, Rossella Villani¹, Teresa Squicciarini¹, Anna Albano¹, Ileana De Roma¹, Fabio Mele ², Margherita Sonnessa², Concetta Saponaro², Francesco Alfredo Zito², Arianna Bozzi³, Benedetta Apollonio¹, Raffaella Massafra³, Michele Guida¹ | ¹Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; ²Pathology Unit, IRCCS Istituto Tumori "Giovanni Paolo II"; ³Biostatistics and Bioinformatics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10755

  317